Abbott Laboratories (NYSE: ABT) Q1 2023 earnings call dated Apr. 19, 2023 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing and Acquisitions
Abbott Laboratories
-(ABT)
XNYS:ABT
Infographic: Highlights of Abbott Laboratories’ Q1 2023 results
Healthcare company Abbott Laboratories (NYSE: ABT) announced financial results for the first quarter of 2023, reporting a decline in net sales and
Key factors to consider before investing in Abbott Laboratories (ABT)
Abbott Laboratories (NYSE: ABT) has contributed significantly to COVID care activities by providing test kits, and the healthcare conglomerate’s revenues benefitted from
Abbott Laboratories (ABT) Q4 2022 Earnings Call Transcript
Abbott Laboratories (NYSE:ABT) Q4 2022 Earnings Call dated Jan. 25, 2023. Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing, and Acquisition
Infographic: How Abbott Laboratories (ABT) performed in Q4 2022 financial results
Abbott Laboratories (NYSE: ABT) reported fourth quarter 2022 earnings results today. Net sales declined 12% year-over-year to $10.1 billion. Net earnings decreased
Abbott (ABT) Q3 2022 Earnings Call Transcript
Abbott (NYSE: ABT) Q3 2022 earnings call dated Oct. 19, 2022 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing, and Acquisition
Key highlights from Abbott (ABT) Q3 2022 earnings results
Abbott (NYSE: ABT) reported third quarter 2022 earnings results today. Sales decreased 4.7% year-over-year to $10.4 billion. On an organic basis, sales
Abbott (ABT) Q2 2022 Earnings Call Transcript
Abbott (NYSE: ABT) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing and Acquisitions Robert
Abbott Laboratories (ABT) Earnings: 2Q22 Key Numbers
Abbott Laboratories (NYSE: ABT) reported second quarter 2022 earnings results. Total sales increased 10.1% year-over-year to $11.3 billion. On an organic basis,
Abbott Laboratories (ABT) stock remains a compelling buy. Here’s why
Like most healthcare-related businesses, Abbott Laboratories (NYSE: ABT) has been operating near full capacity for quite some time, with its diagnostics segment
Abbott Laboratories (ABT) Q1 2022 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q1 2022 earnings call dated Apr. 20, 2022 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations Robert B. Ford -- Chairman
Abbott Laboratories (ABT) Q1 2022 Infographic: Key financials and quarterly highlights
Abbott (NYSE: ABT) today reported its first-quarter financial results for the period ended March 31, 2022. GAAP net earnings for the first
Abbott Laboratories (ABT) Q4 2021 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing & Acquisitions
Abbott Laboratories (ABT) Q3 2021 Earnings: Key financials and quarterly highlights
Abbott (NYSE: ABT) today reported its third quarter financial results for the period ended September 30, 2021. GAAP net earnings for the
Abbott Laboratories (ABT) Q3 2021 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q3 2021 earnings call dated Oct. 20, 2021 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing & Acquisitions
Abbott (ABT) bets on product mix to stay strong. Should you buy the stock?
The healthcare industry remains stressed despite a marked improvement in the pandemic situation, with patient visits increasing steadily and elective procedures resuming.
Abbott Laboratories (ABT) Q2 2021 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q2 2021 earnings call dated Jul. 22, 2021 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing and
Abbott Laboratories ease past street targets: Infographic
Abbott Laboratories (NYSE: ABT) reported second-quarter 2021 financial results before the regular market hours on Thursday. The pharmaceutical giant reported Q2 sales
Earnings calendar for the week of July 19
Despite strong trading and encouraging news from the labor market, benchmark stock indexes pulled back after making modest gains early in the
Abbott Laboratories (ABT) Q1 2021 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Scott Michael Leinenweber -- Vice President of Investor Relations, Licensing
Abbott Laboratories (ABT) Earnings: 1Q21 Key Numbers
Abbott Laboratories (NYSE: ABT) reported first quarter 2021 earnings results today. Sales increased 35.3% year-over-year to $10.5 billion. On an organic basis,